Analyst Ratings for Abbott Laboratories (ABT)

Updated: 2017-07-28

Analysts covering Abbott Laboratories (NYSE:ABT) have given it a consensus rating of Overweight. A consensus rating of Overweight was previously issued for ABT last month.

21 analysts issued ratings on the stock, where 12 gave ABT a buy rating, 1 gave an overweight rating, 8 gave a hold rating, 0 gave an underweight rating, and 0 gave a sell rating. Compared to three months ago, there has been an increase of 2 in the number of analysts with a positive outlook on the stock. During this time, the number of analysts bearish on the stock has increased by 0.

A number of analysts gave price targets for ABT. The maximum price target given was 58, implying potential capital gains of 15.75 percent. The most pessimistic analyst gave a price target of 47, implying potential capital losses of -6.21 percent. It is advisable to not rely only on price targets or ratings, as these can be biased for some stocks.

Analysts have revised their earnings estimates downwards for this quarter, by about -1.52 percent on average, compared to last month. This can be compared with the average change in earnings estimates over the past 3 months, which is -1.52 percent. On the other hand, earnings estimates for the fiscal year have been revised upwards by 0.61 percent, as compared to a month ago. Expanding the time horizon to 3 months, the average change in fiscal year estimates becomes 0.81 percent.

Another thing investors often look at is the level of agreement among analysts' revisions. 4 analysts made positive revisions to their quarterly estimates over the past month, while 6 analysts made negative revisions. During this time, 7 analysts made positive revisions in their estimates for this fiscal year's earnings, compared to 2 analysts that revised their FY estimates downwards.

ABT has an estimated earnings growth rate of 243.76 percent as forecasted by analysts. People on Wall Street often look at a company's PEG ratio. A lower PEG ratio is favorable, because that is often interpreted as the company being fairly priced relative to its growth rate. Wall Street investors typically prefer a PEG ratio to be smaller than 1, though it could be better to see where the ratio stands relative to peers in the industry. ABT has a PEG ratio of 0.29.

ABT has a 52-week high of 51.13 and a 52-week low of 37.38. Today's price is 34.06 percent above the 52-week low, and 1.99 percent below the high. ABT has a price/earnings ratio of 69.92. Investors typically compare the P/E ratio to a company's peers in the industry. The ABT value stock report compares ABT to some of its peers using value stock charts. The market cap of ABT is $87.46 billion. ABT is estimated to release their earnings results for the quarter on 0000-00-00, days from today.